Urinary tract and prostate

5α-Reductase inhibitors

Drugs that block the conversion of testosterone to dihydrotestosterone, shrinking an enlarged prostate over months; they halve the PSA level, which must be taken into account when screening for cancer.

Mechanism of action

Molecular targets

Drugs in 5α-Reductase inhibitors

Therapeutic uses

Diseases it treats

Adverse effects

Contraindications by condition

Other cautions and interactions

Connected topics

Written from

Educational reference. Not medical advice, diagnosis or treatment.